{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T10:27:15Z","timestamp":1786789635683,"version":"build-2736575974"},"reference-count":58,"publisher":"Zhejiang University Press","issue":"8","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Zhejiang Univ. Sci. B"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1631\/jzus.b2500237","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T05:54:19Z","timestamp":1782712459000},"page":"872-887","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neuroprotection of engineered Clostridium butyricum-pMTL007-GLP-1 in A53T \u03b1-synuclein (\u03b1-syn) mouse model via PI3K\/AKT\/GSK-3\u03b2","\u5de5\u7a0b\u83cc Clostridium butyricum-pMTL007-GLP-1 \u901a\u8fc7 PI3K\/AKT\/GSK-3\u03b2 \u4fe1\u53f7\u901a\u8def\u5bf9 A53T \u03b1-\u7a81\u89e6\u6838\u86cb\u767d\u5c0f\u9f20\u6a21\u578b\u7684\u795e\u7ecf\u4fdd\u62a4\u4f5c\u7528"],"prefix":"10.1631","volume":"27","author":[{"given":"Xin","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenli","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daojun","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1501-9922","authenticated-orcid":false,"given":"Jie","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0506-8536","authenticated-orcid":false,"given":"Tingtao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"635","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"key":"846_CR1","doi-asserted-by":"publisher","first-page":"5655","DOI":"10.1038\/s41467-025-60815-0","volume":"16","author":"NI Bohnen","year":"2025","unstructured":"Bohnen NI, Roytman S, van der Zee S, et al., 2025. A multicenter longitudinal study of cholinergic subgroups in Parkinson disease. Nat Commun, 16:5655. https:\/\/doi.org\/10.1038\/s41467-025-60815-0","journal-title":"Nat Commun"},{"key":"846_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40035-022-00285-2","volume":"11","author":"EES Chang","year":"2022","unstructured":"Chang EES, Ho PWL, Liu HF, et al., 2022. LRRK2 mutant knockin mouse models: therapeutic relevance in Parkinson\u2019s disease. Transl Neurodegener, 11:10. https:\/\/doi.org\/10.1186\/s40035-022-00285-2","journal-title":"Transl Neurodegener"},{"issue":"17","key":"846_CR3","doi-asserted-by":"publisher","first-page":"7565","DOI":"10.1007\/s00253-018-9155-6","volume":"102","author":"TT Chen","year":"2018","unstructured":"Chen TT, Tian PY, Huang ZX, et al., 2018. Engineered commensal bacteria prevent systemic inflammation-induced memory impairment and amyloidogenesis via producing GLP-1. Appl Microbiol Biotechnol, 102(17):7565\u20137575. https:\/\/doi.org\/10.1007\/s00253-018-9155-6","journal-title":"Appl Microbiol Biotechnol"},{"key":"846_CR4","doi-asserted-by":"publisher","first-page":"107988","DOI":"10.1016\/j.pharmthera.2021.107988","volume":"231","author":"SB Chidambaram","year":"2022","unstructured":"Chidambaram SB, Essa MM, Rathipriya AG, et al., 2022. Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: tales of a vicious cycle. Pharmacol Ther, 231:107988. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107988","journal-title":"Pharmacol Ther"},{"issue":"5","key":"846_CR5","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/cdd.2014.179","volume":"22","author":"JJ Credle","year":"2015","unstructured":"Credle JJ, George JL, Wills J, et al., 2015. GSK-3\u03b2 dysregulation contributes to Parkinson\u2019s-like pathophysiology with associated region-specific phosphorylation and accumulation of Tau and \u03b1-synuclein. Cell Death Differ, 22(5):838\u2013851. https:\/\/doi.org\/10.1038\/cdd.2014.179","journal-title":"Cell Death Differ"},{"issue":"2","key":"846_CR6","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.bbrc.2016.01.035","volume":"470","author":"C Cui","year":"2016","unstructured":"Cui C, Cui NS, Wang P, et al., 2016. Neuroprotective effect of sulfated polysaccharide isolated from sea cucumber Stichopus japonicus on 6-OHDA-induced death in SH-SY5Y through inhibition of MAPK and NF-\u03baB and activation of PI3K\/Akt signaling pathways. Biochem Biophys Res Commun, 470(2):375\u2013383. https:\/\/doi.org\/10.1016\/j.bbrc.2016.01.035","journal-title":"Biochem Biophys Res Commun"},{"key":"846_CR7","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13568-020-01014-6","volume":"10","author":"X Fang","year":"2020","unstructured":"Fang X, Zhou XT, Miao YQ, et al., 2020. Therapeutic effect of GLP-1 engineered strain on mice model of Alzheimer\u2019s disease and Parkinson\u2019s disease. AMB Express, 10:80. https:\/\/doi.org\/10.1186\/s13568-020-01014-6","journal-title":"AMB Express"},{"key":"846_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.phrs.2015.03.010","volume":"97","author":"M Golpich","year":"2015","unstructured":"Golpich M, Amini E, Hemmati F, et al., 2015. Glycogen synthase kinase-3 beta (GSK-3\u03b2) signaling: implications for Parkinson\u2019s disease. Pharmacol Res, 97:16\u201326. https:\/\/doi.org\/10.1016\/j.phrs.2015.03.010","journal-title":"Pharmacol Res"},{"key":"846_CR9","doi-asserted-by":"publisher","first-page":"112776","DOI":"10.1016\/j.biopha.2022.112776","volume":"148","author":"MA Gowayed","year":"2022","unstructured":"Gowayed MA, El-Sayed NS, Matar NA, et al., 2022. The \u03b17 nAChR allosteric modulator PNU-120596 amends neuroinflammatory and motor consequences of parkinsonism in rats: role of JAK2\/NF-\u03baB\/GSk3\u03b2\/TNF-\u03b1 pathway. Biomed Pharmacother, 148:112776. https:\/\/doi.org\/10.1016\/j.biopha.2022.112776","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"846_CR10","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1002\/jnr.22331","volume":"88","author":"DR Graham","year":"2010","unstructured":"Graham DR, Sidhu A, 2010. Mice expressing the A53T mutant form of human alpha-synuclein exhibit hyperactivity and reduced anxiety-like behavior. J Neurosci Res, 88(8):1777\u20131783. https:\/\/doi.org\/10.1002\/jnr.22331","journal-title":"J Neurosci Res"},{"key":"846_CR11","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.brainres.2007.04.034","volume":"1155","author":"S Higashi","year":"2007","unstructured":"Higashi S, Biskup S, West AB, et al., 2007. Localization of Parkinson\u2019s disease-associated LRRK2 in normal and pathological human brain. Brain Res, 1155:208\u2013219. https:\/\/doi.org\/10.1016\/j.brainres.2007.04.034","journal-title":"Brain Res"},{"key":"846_CR12","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.neuropharm.2018.01.040","volume":"136","author":"C H\u00f6lscher","year":"2018","unstructured":"H\u00f6lscher C, 2018. Novel dual GLP-1\/GIP receptor agonists show neuroprotective effects in Alzheimer\u2019s and Parkinson\u2019s disease models. Neuropharmacology, 136:251\u2013259. https:\/\/doi.org\/10.1016\/j.neuropharm.2018.01.040","journal-title":"Neuropharmacology"},{"issue":"4","key":"846_CR13","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","volume":"87","author":"JJ Holst","year":"2007","unstructured":"Holst JJ, 2007. The physiology of glucagon-like peptide 1. Physiol Rev, 87(4):1409\u20131439. https:\/\/doi.org\/10.1152\/physrev.00034.2006","journal-title":"Physiol Rev"},{"issue":"2","key":"846_CR14","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/cmdc.200500039","volume":"1","author":"AP Kozikowski","year":"2006","unstructured":"Kozikowski AP, Gaisina IN, Petukhov PA, et al., 2006. Highly potent and specific GSK-3\u03b2 inhibitors that block Tau phosphorylation and decrease \u03b1-synuclein protein expression in a cellular model of Parkinson\u2019s disease. ChemMedChem, 1(2):256\u2013266. https:\/\/doi.org\/10.1002\/cmdc.200500039","journal-title":"ChemMedChem"},{"issue":"10","key":"846_CR15","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1007\/s11064-018-2620-x","volume":"43","author":"F Lai","year":"2018","unstructured":"Lai F, Jiang R, Xie WJ, et al., 2018. Intestinal pathology and gut microbiota alterations in a methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson\u2019s disease. Neurochem Res, 43(10):1986\u20131999. https:\/\/doi.org\/10.1007\/s11064-018-2620-x","journal-title":"Neurochem Res"},{"key":"846_CR16","doi-asserted-by":"publisher","first-page":"15625","DOI":"10.1038\/s41598-018-33893-y","volume":"8","author":"ZL Lai","year":"2018","unstructured":"Lai ZL, Tseng CH, Ho HJ, et al., 2018. Fecal microbiota transplantation confers beneficial metabolic effects of diet and exercise on diet-induced obese mice. Sci Rep, 8: 15625. https:\/\/doi.org\/10.1038\/s41598-018-33893-y","journal-title":"Sci Rep"},{"key":"846_CR17","doi-asserted-by":"publisher","first-page":"189246","DOI":"10.4061\/2011\/189246","volume":"2011","author":"P Lei","year":"2011","unstructured":"Lei P, Ayton S, Bush AI, et al., 2011. GSK-3 in neurodegenerative diseases. Int J Alzheimers Dis, 2011:189246. https:\/\/doi.org\/10.4061\/2011\/189246","journal-title":"Int J Alzheimers Dis"},{"issue":"8","key":"846_CR18","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.3233\/JPD-223431","volume":"12","author":"F Liang","year":"2022","unstructured":"Liang F, Chen CY, Li YP, et al., 2022. Early dysbiosis and dampened gut microbe oscillation precede motor dysfunction and neuropathology in animal models of Parkinson\u2019s disease. J Parkinsons Dis, 12(8):2423\u20132440. https:\/\/doi.org\/10.3233\/JPD-223431","journal-title":"J Parkinsons Dis"},{"key":"846_CR19","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12974-019-1528-y","volume":"16","author":"CH Lin","year":"2019","unstructured":"Lin CH, Chen CC, Chiang HL, et al., 2019. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson\u2019s disease. J Neuroinflammation, 16:129. https:\/\/doi.org\/10.1186\/s12974-019-1528-y","journal-title":"J Neuroinflammation"},{"key":"846_CR20","doi-asserted-by":"publisher","first-page":"665520","DOI":"10.3389\/fmed.2021.665520","volume":"8","author":"R Liptak","year":"2021","unstructured":"Liptak R, Gromova B, Gardlik R, 2021. Fecal microbiota transplantation as a tool for therapeutic modulation of non-gastrointestinal disorders. Front Med, 8:665520. https:\/\/doi.org\/10.3389\/fmed.2021.665520","journal-title":"Front Med"},{"issue":"1","key":"846_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1631\/jzus.B2300343","volume":"26","author":"ML Liu","year":"2025","unstructured":"Liu ML, Fan GH, Meng LK, et al., 2025. New perspectives on microbiome-dependent gut-brain pathways for the treatment of depression with gastrointestinal symptoms: from bench to bedside. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 26(1):1\u201325. https:\/\/doi.org\/10.1631\/jzus.B2300343","journal-title":"J Zhejiang Univ-Sci B (Biomed & Biotechnol)"},{"issue":"6","key":"846_CR22","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1007\/s11064-021-03293-2","volume":"46","author":"XR Liu","year":"2021","unstructured":"Liu XR, Liu SY, Tang Y, et al., 2021. Intragastric administration of casein leads to nigrostriatal disease progressed accompanied with persistent nigrostriatal-intestinal inflammation activited and intestinal microbiota-metabolic disorders induced in MPTP mouse model of Parkinson\u2019s disease. Neurochem Res, 46(6):1514\u20131539. https:\/\/doi.org\/10.1007\/s11064-021-03293-2","journal-title":"Neurochem Res"},{"issue":"14","key":"846_CR23","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1016\/j.bmcl.2013.05.022","volume":"23","author":"M Lorenz","year":"2013","unstructured":"Lorenz M, Evers A, Wagner M, 2013. Recent progress and future options in the development of GLP-1 receptor agonists for the treatment of diabesity. Bioorg Med Chem Lett, 23(14):4011\u20134018. https:\/\/doi.org\/10.1016\/j.bmcl.2013.05.022","journal-title":"Bioorg Med Chem Lett"},{"key":"846_CR24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40035-020-00213-2","volume":"9","author":"LL Lv","year":"2020","unstructured":"Lv LL, Tan XL, Peng XK, et al., 2020. The relationships of vitamin D, vitamin D receptor gene polymorphisms, and vitamin D supplementation with Parkinson\u2019s disease. Transl Neurodegener, 9:34. https:\/\/doi.org\/10.1186\/s40035-020-00213-2","journal-title":"Transl Neurodegener"},{"issue":"53","key":"846_CR25","doi-asserted-by":"publisher","first-page":"14363","DOI":"10.1523\/JNEUROSCI.3928-08.2008","volume":"28","author":"C Malagelada","year":"2008","unstructured":"Malagelada C, Jin ZH, Greene LA, 2008. RTP801 is induced in Parkinson\u2019s disease and mediates neuron death by inhibiting Akt phosphorylation\/activation. J Neurosci, 28(53): 14363\u201314371. https:\/\/doi.org\/10.1523\/JNEUROSCI.3928-08.2008","journal-title":"J Neurosci"},{"issue":"4","key":"846_CR26","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.stemcr.2016.02.002","volume":"6","author":"JR Meng","year":"2016","unstructured":"Meng JR, Ma X, Wang N, et al., 2016. Activation of GLP-1 receptor promotes bone marrow stromal cell osteogenic differentiation through \u03b2-catenin. Stem Cell Rep, 6(4): 579\u2013591. https:\/\/doi.org\/10.1016\/j.stemcr.2016.02.002","journal-title":"Stem Cell Rep"},{"issue":"2","key":"846_CR27","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.neuron.2009.01.033","volume":"62","author":"EV Mosharov","year":"2009","unstructured":"Mosharov EV, Larsen KE, Kanter E, et al., 2009. Interplay between cytosolic dopamine, calcium, and \u03b1-synuclein causes selective death of substantia nigra neurons. Neuron, 62(2):218\u2013229. https:\/\/doi.org\/10.1016\/j.neuron.2009.01.033","journal-title":"Neuron"},{"issue":"7","key":"846_CR28","doi-asserted-by":"publisher","first-page":"D012990","DOI":"10.1002\/14651858.CD012990.pub2","volume":"7","author":"CA Mulvaney","year":"2020","unstructured":"Mulvaney CA, Duarte GS, Handley J, et al., 2020. GLP-1 receptor agonists for Parkinson\u2019s disease. Cochrane Database Syst Rev, 7(7):CD012990. https:\/\/doi.org\/10.1002\/14651858.CD012990.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"846_CR29","doi-asserted-by":"publisher","first-page":"970925","DOI":"10.3389\/fnins.2022.970925","volume":"16","author":"N Reich","year":"2022","unstructured":"Reich N, H\u00f6lscher C, 2022. The neuroprotective effects of glucagon-like peptide 1 in Alzheimer\u2019s and Parkinson\u2019s disease: an in-depth review. Front Neurosci, 16:970925. https:\/\/doi.org\/10.3389\/fnins.2022.970925","journal-title":"Front Neurosci"},{"issue":"5","key":"846_CR30","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/glia.20947","volume":"58","author":"AI Rojo","year":"2010","unstructured":"Rojo AI, Innamorato NG, Mart\u00edn-Moreno AM, et al., 2010. Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson\u2019s disease. Glia, 58(5):588\u2013598. https:\/\/doi.org\/10.1002\/glia.20947","journal-title":"Glia"},{"issue":"11","key":"846_CR31","doi-asserted-by":"publisher","first-page":"6834","DOI":"10.1007\/s12035-022-03005-z","volume":"59","author":"N Sharma","year":"2022","unstructured":"Sharma N, Soni R, Sharma M, et al., 2022. Chlorogenic acid: a polyphenol from coffee rendered neuroprotection against rotenone-induced Parkinson\u2019s disease by GLP-1 secretion. Mol Neurobiol, 59(11):6834\u20136856. https:\/\/doi.org\/10.1007\/s12035-022-03005-z","journal-title":"Mol Neurobiol"},{"issue":"4","key":"846_CR32","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/73902","volume":"3","author":"MP Smidt","year":"2000","unstructured":"Smidt MP, Asbreuk CHJ, Cox JJ, et al., 2000. A second independent pathway for development of mesencephalic dopaminergic neurons requires Lmx1b. Nat Neurosci, 3(4): 337\u2013341. https:\/\/doi.org\/10.1038\/73902","journal-title":"Nat Neurosci"},{"key":"846_CR33","doi-asserted-by":"publisher","first-page":"107978","DOI":"10.1016\/j.pharmthera.2021.107978","volume":"231","author":"S Snigdha","year":"2022","unstructured":"Snigdha S, Ha K, Tsai P, et al., 2022. Probiotics: potential novel therapeutics for microbiota-gut-brain axis dysfunction across gender and lifespan. Pharmacol Ther, 231: 107978. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107978","journal-title":"Pharmacol Ther"},{"issue":"1","key":"846_CR34","doi-asserted-by":"publisher","first-page":"1907272","DOI":"10.1080\/19490976.2021.1907272","volume":"13","author":"MK Stoeva","year":"2021","unstructured":"Stoeva MK, Garcia-So J, Justice N, et al., 2021. Butyrateproducing human gut symbiont, Clostridium butyricum, and its role in health and disease. Gut Microbes, 13(1): 1907272. https:\/\/doi.org\/10.1080\/19490976.2021.1907272","journal-title":"Gut Microbes"},{"key":"846_CR35","doi-asserted-by":"publisher","first-page":"175029","DOI":"10.1016\/j.ejphar.2022.175029","volume":"926","author":"YF Su","year":"2022","unstructured":"Su YF, Liu NN, Zhang ZJ, et al., 2022. Cholecystokinin and glucagon-like peptide-1 analogues regulate intestinal tight junction, inflammation, dopaminergic neurons and \u03b1-synuclein accumulation in the colon of two Parkinson\u2019s disease mouse models. Eur J Pharmacol, 926:175029. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175029","journal-title":"Eur J Pharmacol"},{"key":"846_CR36","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s12974-020-01911-4","volume":"17","author":"MS Subbarayan","year":"2020","unstructured":"Subbarayan MS, Hudson C, Moss LD, et al., 2020. T cell infiltration and upregulation of MHC II in microglia leads to accelerated neuronal loss in an \u03b1-synuclein rat model of Parkinson\u2019s disease. J Neuroinflammation, 17:242. https:\/\/doi.org\/10.1186\/s12974-020-01911-4","journal-title":"J Neuroinflammation"},{"key":"846_CR37","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.bbi.2020.10.014","volume":"91","author":"J Sun","year":"2021","unstructured":"Sun J, Li HJ, Jin YJ, et al., 2021. Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson\u2019s disease via gut microbiota-GLP-1 pathway. Brain Behav Immun, 91:703\u2013715. https:\/\/doi.org\/10.1016\/j.bbi.2020.10.014","journal-title":"Brain Behav Immun"},{"issue":"3","key":"846_CR38","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.nbd.2009.11.004","volume":"37","author":"MG Tansey","year":"2010","unstructured":"Tansey MG, Goldberg MS, 2010. Neuroinflammation in Parkinson\u2019s disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol Dis, 37(3): 510\u2013518. https:\/\/doi.org\/10.1016\/j.nbd.2009.11.004","journal-title":"Neurobiol Dis"},{"issue":"21","key":"846_CR39","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1001\/jama.2012.4829","volume":"307","author":"D Tarsy","year":"2012","unstructured":"Tarsy D, 2012. Treatment of Parkinson disease: a 64-year-old man with motor complications of advanced Parkinson disease. JAMA, 307(21):2305\u20132314. https:\/\/doi.org\/10.1001\/jama.2012.4829","journal-title":"JAMA"},{"key":"846_CR40","doi-asserted-by":"publisher","first-page":"100888","DOI":"10.1016\/j.crfs.2024.100888","volume":"9","author":"F Tripodi","year":"2024","unstructured":"Tripodi F, Lambiase A, Moukham H, et al., 2024. Targeting protein aggregation using a cocoa-bean shell extract to reduce \u03b1-synuclein toxicity in models of Parkinson\u2019s disease. Curr Res Food Sci, 9:100888. https:\/\/doi.org\/10.1016\/j.crfs.2024.100888","journal-title":"Curr Res Food Sci"},{"key":"846_CR41","doi-asserted-by":"publisher","first-page":"e251904","DOI":"10.1001\/jamaneurol.2025.1904","volume":"14","author":"CP Vaughan","year":"2025","unstructured":"Vaughan CP, Morley JF, Lehosit J, et al., 2025. Behavioral compared with drug therapy for overactive bladder symptoms in Parkinson disease: a randomized noninferiority trial. JAMA Neurol, 14:e251904. https:\/\/doi.org\/10.1001\/jamaneurol.2025.1904","journal-title":"JAMA Neurol"},{"issue":"9","key":"846_CR42","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1093\/brain\/awab156","volume":"144","author":"Q Wang","year":"2021","unstructured":"Wang Q, Luo YQ, Ray Chaudhuri K, et al., 2021. The role of gut dysbiosis in Parkinson\u2019s disease: mechanistic insights and therapeutic options. Brain, 144(9):2571\u20132593. https:\/\/doi.org\/10.1093\/brain\/awab156","journal-title":"Brain"},{"key":"846_CR43","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","volume":"4","author":"QQ Wang","year":"2015","unstructured":"Wang QQ, Liu YJ, Zhou JW, 2015. Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target. Transl Neurodegener, 4:19. https:\/\/doi.org\/10.1186\/s40035-015-0042-0","journal-title":"Transl Neurodegener"},{"key":"846_CR44","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.neuropharm.2017.11.048","volume":"131","author":"Y Wang","year":"2018","unstructured":"Wang Y, Chen S, Xu Z, et al., 2018. GLP-1 receptor agonists downregulate aberrant GnT-III expression in Alzheimer\u2019s disease models through the Akt\/GSK-3\u03b2\/\u03b2-catenin signaling. Neuropharmacology, 131:190\u2013199. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.11.048","journal-title":"Neuropharmacology"},{"issue":"3","key":"846_CR45","doi-asserted-by":"publisher","first-page":"e10505","DOI":"10.1002\/btm2.10505","volume":"8","author":"Y Wang","year":"2023","unstructured":"Wang Y, Chen WJ, Han YY, et al., 2023. Neuroprotective effect of engineered Clostridium butyricum-pMTL007-GLP-1 on Parkinson\u2019s disease mice models via promoting mitophagy. Bioeng Transl Med, 8(3):e10505. https:\/\/doi.org\/10.1002\/btm2.10505","journal-title":"Bioeng Transl Med"},{"key":"846_CR46","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1750-1326-6-38","volume":"6","author":"ZQ Wang","year":"2011","unstructured":"Wang ZQ, Zhang Y, Zhang S, et al., 2011. DJ-1 can inhibit microtubule associated protein 1 B formed aggregates. Mol Neurodegener, 6:38. https:\/\/doi.org\/10.1186\/1750-1326-6-38","journal-title":"Mol Neurodegener"},{"issue":"5","key":"846_CR47","doi-asserted-by":"publisher","first-page":"e10351","DOI":"10.1002\/btm2.10351","volume":"8","author":"H Wu","year":"2023","unstructured":"Wu H, Wei J, Zhao XM, et al., 2023. Neuroprotective effects of an engineered Escherichia coli Nissle 1917 on Parkinson\u2019s disease in mice by delivering GLP-1 and modulating gut microbiota. Bioeng Transl Med, 8(5):e10351. https:\/\/doi.org\/10.1002\/btm2.10351","journal-title":"Bioeng Transl Med"},{"issue":"3","key":"846_CR48","doi-asserted-by":"publisher","first-page":"234","DOI":"10.14348\/molcells.2018.2340","volume":"41","author":"X Wu","year":"2018","unstructured":"Wu X, Li S, Xue P, et al., 2018. Liraglutide inhibits the apoptosis of MC3T3-E1 cells induced by serum deprivation through cAMP\/PKA\/\u03b2-catenin and PI3K\/AKT\/GSK3\u03b2 signaling pathways. Mol Cells, 41(3):234\u2013243. https:\/\/doi.org\/10.14348\/molcells.2018.2340","journal-title":"Mol Cells"},{"key":"846_CR49","doi-asserted-by":"publisher","first-page":"115658","DOI":"10.1016\/j.taap.2021.115658","volume":"427","author":"WX Xu","year":"2021","unstructured":"Xu WX, Qi YZ, Gao YJ, et al., 2021. Benzo(a)pyrene exposure in utero exacerbates Parkinson\u2019s Disease (PD)-like \u03b1-synucleinopathy in A53T human alpha-synuclein transgenic mice. Toxicol Appl Pharmacol, 427:115658. https:\/\/doi.org\/10.1016\/j.taap.2021.115658","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"846_CR50","doi-asserted-by":"publisher","first-page":"13","DOI":"10.20517\/mrr.2023.68","volume":"3","author":"X Xu","year":"2024","unstructured":"Xu X, Xu TC, Wei J, et al., 2024. Gut microbiota: an ideal biomarker and intervention strategy for aging. Microbiome Res Rep, 3(2):13. https:\/\/doi.org\/10.20517\/mrr.2023.68","journal-title":"Microbiome Res Rep"},{"issue":"5","key":"846_CR51","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.3892\/mmr.2014.2563","volume":"10","author":"JQ Yan","year":"2014","unstructured":"Yan JQ, Fu QZ, Cheng LN, et al., 2014. Inflammatory response in Parkinson\u2019s disease (Review). Mol Med Rep, 10(5): 2223\u20132233. https:\/\/doi.org\/10.3892\/mmr.2014.2563","journal-title":"Mol Med Rep"},{"key":"846_CR52","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1423-0127-21-20","volume":"21","author":"JCS Yang","year":"2014","unstructured":"Yang JCS, Wu SC, Rau CS, et al., 2014. Inhibition of the phosphoinositide 3-kinase pathway decreases innate resistance to lipopolysaccharide toxicity in TLR4 deficient mice. J Biomed Sci, 21:20. https:\/\/doi.org\/10.1186\/1423-0127-21-20","journal-title":"J Biomed Sci"},{"issue":"12","key":"846_CR53","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.7150\/thno.15993","volume":"6","author":"JL Yang","year":"2016","unstructured":"Yang JL, Chen WY, Chen YP, et al., 2016. Activation of GLP-1 receptor enhances neuronal base excision repair via PI3K-AKT-induced expression of apurinic\/apyrimidinic endonuclease 1. Theranostics, 6(12):2015\u20132027. https:\/\/doi.org\/10.7150\/thno.15993","journal-title":"Theranostics"},{"key":"846_CR54","doi-asserted-by":"publisher","first-page":"630962","DOI":"10.3389\/fmed.2021.630962","volume":"8","author":"MY Yao","year":"2021","unstructured":"Yao MY, Zhang J, Li ZH, et al., 2021. Liraglutide protects nucleus pulposus cells against high-glucose induced apoptosis by activating PI3K\/Akt\/mTOR\/caspase-3 and PI3K\/Akt\/GSK3\u03b2\/caspase-3 signaling pathways. Front Med, 8: 630962. https:\/\/doi.org\/10.3389\/fmed.2021.630962","journal-title":"Front Med"},{"issue":"5","key":"846_CR55","doi-asserted-by":"publisher","first-page":"786","DOI":"10.7150\/jca.17712","volume":"8","author":"CY Zeng","year":"2017","unstructured":"Zeng CY, Chen TT, Zhang Y, et al., 2017. Hedgehog signaling pathway regulates ovarian cancer invasion and migration via adhesion molecule CD24. J Cancer, 8(5):786\u2013792. https:\/\/doi.org\/10.7150\/jca.17712","journal-title":"J Cancer"},{"key":"846_CR56","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12934-024-02389-y","volume":"23","author":"YC Zhang","year":"2024","unstructured":"Zhang YC, Bailey TS, Hittmeyer P, et al., 2024. Multiplex genetic manipulations in Clostridium butyricum and Clostridium sporogenes to secrete recombinant antigen proteins for oral-spore vaccination. Microb Cell Fact, 23:119. https:\/\/doi.org\/10.1186\/s12934-024-02389-y","journal-title":"Microb Cell Fact"},{"issue":"39","key":"846_CR57","doi-asserted-by":"publisher","first-page":"10697","DOI":"10.1021\/acs.jafc.0c04370","volume":"68","author":"BT Zhao","year":"2020","unstructured":"Zhao BT, Xia B, Li XH, et al., 2020. Sesamol supplementation attenuates DSS-induced colitis via mediating gut barrier integrity, inflammatory responses, and reshaping gut microbiome. J Agric Food Chem, 68(39):10697\u201310708. https:\/\/doi.org\/10.1021\/acs.jafc.0c04370","journal-title":"J Agric Food Chem"},{"issue":"12","key":"846_CR58","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.3390\/microorganisms8121907","volume":"8","author":"M Zommiti","year":"2020","unstructured":"Zommiti M, Feuilloley MGJ, Connil N, 2020. Update of probiotics in human world: a nonstop source of benefactions till the end of time. Microorganisms, 8(12):1907. https:\/\/doi.org\/10.3390\/microorganisms8121907","journal-title":"Microorganisms"}],"container-title":["Journal of Zhejiang University-SCIENCE B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B2500237.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1631\/jzus.B2500237","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B2500237.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T10:02:21Z","timestamp":1786788141000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1631\/jzus.B2500237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":58,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["846"],"URL":"https:\/\/doi.org\/10.1631\/jzus.b2500237","relation":{},"ISSN":["1673-1581","1862-1783"],"issn-type":[{"value":"1673-1581","type":"print"},{"value":"1862-1783","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]},"assertion":[{"value":"9 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Xin FANG, Yun WANG, Zhenli LONG, Bin LIAO, Bo WANG, Daojun HONG, Jie LUO, and Tingtao CHEN declare that they have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethics guidelines"}},{"value":"Animal care protocols and all experimental procedures adhered to National Institutes of Health guidelines and were approved by the Animal Experimental Ethical Inspection Committee of Nanchang Royo Biotechnology Co., Ltd., Nanchang, China (Approval No. RyE2021070912).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethics guidelines"}}]}}